GUY NOHRA
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
MORDECHAY ALTARAC, RAY BAKER, ROBIN BELLAS, JACK CARLSON, EARL FENDER, EARL R. FENDER, SAMI HAMADE, KEEGAN HARPER, MICHAEL HUGHES, WILLIAM JOSEPH, PETER KLEIN, PETER JUSTIN KLEIN, PAUL KLINGENSTEIN, SCOTT C. LYNCH, ANTHONY G. MAURIELLO, J. CASEY MCGLYNN, GUY P NOHRA, GUY P. NOHRA, R. STEPHEN REITZLER, ROBERT REITZLER, ROBERT S. REITZLER, ALEXANDER SCHMITZ, JEFFREY A. SWIECKE, JEFF SWIECKI, JEFFREY A. SWIECKI, JAMES THOMAS, KATHY TUNE, SIGRID VAN BLADEL, MICHAEL WASSERMAN, MARTIN J. WATERS
DIRECTOR
DIRECTOR
ADRIAN ADAMS, RICHARD AFABLE, VINCENT ANGOTTI, VINCENT J ANGOTTI, VINCENT J. ANGOTTI, RAFFI ASADORIAN, SHAKIL ASLAM, MARINA BOZILENKO, JILL BROADFOOT, ANIL DASU, BADRI DASU, BADRI N. DASU, BADRI P DASU, MARK EDWARDS, LARRY HAMEL, STEPHEN HOFFMAN, STEPHEN J HOFFMAN, STEPHEN J. HOFFMAN, ABHINAV JAIN, LINDA JUDGE, CARTER KING, RICHARD KING, HAMEL G. LAWRENCE, PAMELA PALMER, PAMELA P PALMER, PAMELA P. PALMER, HOWARD ROSEN, HOWARD B ROSEN, HOWARD B. ROSEN, HOWIE ROSEN, THOMAS SCHRECK, THOMAS A SCHRECK, STEVE SULLIVAN, MARK WAN, MARK B WEEKS, JAMES WELCH, JAMES H. WELCH
DIRECTOR
DIRECTOR
DIRECTOR
STEVEN BASTA, STEVEN L. BASTA, ALBERT CHA, DAVID CLAPPER, GEORGE DANILOFF, ROXANNE DUBOIS, CHRIS EHRLICH, DAVID GRAVETT, DAVID M. GRAVETT, KEITH A. KATKIN, HAYLEY LEWIS, MARCEE MARONEY, MARCEE M. MARONEY, GUY P. NOHRA, DAVID M. RENZI, TIMOTHY L. TRAPP, EDWARD W. UNKART, MARK WEEKS, T. MICHAEL WHITE, REZA ZADNO
DIRECTOR
ROBERT ALEXANDER, STEPHEN R ASH, STEPHEN R. ASH, JOY BARTON, NELS BERGMARK, NELS P. BERGMARK, TODD CREECH, MILES B. DAVIS, ALVARO F GUILLEM, ALVARO F. GUILLEM, DONALD JEFFERY KEYSER, DONALD JEFFREY KEYSER, WILLIAM KUSHNER, JOHN MCKEARN, TIM OPLER, MARC OSTRO, HENRICK SANDVAD RASMUSSEN, HENRIK SANDVAD RASMUSSEN, CYNTHIA SMITH, ROBERT B TRUITT, ROBERT B. TRUITT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-06-01
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2011-06-29

